HomeStock ScreenerLactose

Lactose Share Price | Lactose Stock Screener

LACTOSE Pharmaceuticals
Share Price BSE
₹127.75
▲ 7.40 (6.15%)
2026-05-20 00:00:00
As of May 20, 2026, the Lactose share price (BSE: LACTOSE) is ₹127.75, up 6.15% from the previous close, with shares trading between ₹116.05 and ₹133.90, and a 52-week range of ₹78.19–₹132.00. Check LACTOSE 52-week performance for the annual price range and momentum. Use the Lactose stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Lactose Market Cap ₹152.26 Cr.
LACTOSE P/E Ratio (TTM) 30.63
Lactose P/B Ratio 2.37
EPS (TTM) ₹4.10
Dividend Yield -
Debt to Equity 0.91
LACTOSE 52 Week High ₹132.00
Lactose 52 Week Low ₹78.19
Operating Margin 11.00%
Profit Margin 3.40%
LACTOSE Revenue (TTM) ₹147.00
EBITDA ₹18.00
Net Income ₹5.00
Total Assets ₹134.00
Total Equity ₹59.00

Lactose Share Price Chart

Screen Lactose share price with an interactive chart. Analyse LACTOSE price trends and volatility across different timeframes.

Lactose Company Profile - Fundamental Screener

Screen Lactose company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for LACTOSE shares.
Sector Healthcare
Industry Pharmaceuticals
Sub-Sector Pharmaceuticals
Segment E
ISIN INE058I01013

Lactose Balance Sheet Screener

Screen LACTOSE balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
Item 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016
Assets
Total Assets 134 101 101 90 88 84 82 83 85 83
Current Assets 57 36 37 23 20 20 18 17 18 17
Fixed Assets 52 55 56 59 60 62 60 63 64 61
Liabilities
Total Liabilities 0 0 0 0 0 0 0 0 0 0
Current Liabilities 30 28 34 36 42 38 35 38 31 37
Non-Current Liabilities 0 0 0 0 0 0 0 0 0 0
Shareholders' Equity
Total Equity 59 47 41 39 35 34 34 32 27 20
Share Capital 13 13 13 13 11 10 10 10 10 9
Reserves & Surplus 40 35 28 27 23 24 24 21 17 11

Lactose Income Statement Screener - Profit & Revenue Analysis

Screen Lactose income statement and profit fundamentals. Analyze LACTOSE quarterly results, revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Lactose share price evaluation.
Item None-None 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March 2016-March 2015-March
Revenue 147 118 115 67 47 35 40 41 32 37 36 24
Expenses 129 99 95 54 34 29 31 31 26 24 24 19
EBITDA 18 18 20 12 13 7 10 10 6 12 12 5
Operating Profit % 11.00% 15.00% 17.00% 17.00% 27.00% 18.00% 23.00% 24.00% 18.00% 32.00% 30.00% 22.00%
Depreciation 6 5 5 5 5 4 4 4 4 3 3 2
Interest 5 6 5 6 5 5 6 5 6 5 4 3
Profit Before Tax 7 7 10 2 3 -3 0 1 -3 4 4 1
Tax 1 2 3 0 1 -1 0 0 -1 2 1 0
Net Profit 5 5 7 1 3 -3 0 1 -1 3 3 1
EPS 3.80 4.10 5.39 0.96 2.10 -2.40 0.07 0.71 -1.37 2.88 3.30 0.60

Lactose Cash Flow Screener - Liquidity Fundamentals

Screen LACTOSE cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
Item 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March 2016-March
Operating Activities 0 9 8 9 2 7 5 0 8 2
Investing Activities -16 -2 -1 -1 -6 -3 -2 -2 -5 4
Financing Activities 19 -6 -8 -8 5 -4 -5 4 -3 -5
Net Cash Flow 3 1 -1 0 1 1 -2 3 0 0

Lactose Shareholding Pattern Screener

See Lactose shareholding pattern with promoter, FII, and DII holdings. Check Lactose promoter holding and ownership changes for LACTOSE on TickJournal.
Item 2026-Mar 2025-Dec 2025-Sept 2025-Jun 2025-Mar 2024-Dec 2024-Sept 2024-Jun
Promoter Holding 53.65% 53.65% 53.65% 53.65% 53.65% 53.65% 53.65% 53.65%
FII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
DII Holding 0.62% 0.62% 0.62% 0.62% 0.62% 0.62% 0.62% 0.62%
Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 38.18% 38.07% 38.12% 38.24% 38.31% 38.08% 39.57% 39.63%
Other Holding 7.55% 7.67% 7.62% 7.50% 7.42% 7.65% 6.17% 6.10%
Shareholder Count 16,670 16,770 16,810 17,013 17,082 17,115 16,998 16,630

Lactose Share Dividend Screener - Share Yield Analysis

Check Lactose dividend history with payout and yield data. View Lactose dividend details including ex-dates and amounts for LACTOSE stock.
No dividends declared by Lactose.

Lactose Stock Index Membership

See which indices include Lactose stock. Check LACTOSE index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Lactose is not part of any tracked indices.
Only major market indices are tracked in our system.

Lactose Market Events Screener - Corporate Actions

Get Lactose corporate actions including splits, bonuses, and buybacks. Check Lactose stock events that may affect LACTOSE share price.
Announcement Date Record Date Event Type Information Price Impact
Annual General Meeting NA -4.46%
Annual General Meeting NA -5.03%
2026-03-28 2026-03-28 Extraordinary General Meeting NA -19.52%
2026-02-13 2026-02-13 Quarterly Result Announcement NA 4.09%
2025-11-13 2025-11-13 Quarterly Result Announcement NA -5.35%
2025-08-13 2025-08-13 Quarterly Result Announcement NA -0.29%
2025-05-30 2025-05-30 Quarterly Result Announcement NA -1.58%
2025-02-12 2025-02-12 Quarterly Result Announcement NA -9.38%
2024-11-15 2024-11-15 Extraordinary General Meeting NA -0.82%
2024-10-15 2024-10-15 Quarterly Result Announcement NA 13.21%

Lactose Competitors Screener - Peer Comparison

Screen LACTOSE competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Sun Pharmaceutical 450,643 40.81 54,729 9.71% 10,980 64.89
Divis Laboratories 179,470 74.13 9,712 18.67% 2,191 64.06
Torrent Pharmaceuticals 149,109 65.68 11,539 6.99% 1,911 58.52
Cipla 115,682 30.09 27,712 -2.46% 3,783 69.78
Dr Reddys Laboratories 111,567 26.16 33,593 -0.44% 3,998 59.87
Lupin 104,032 19.28 27,488 19.98% 5,345 46.11
Mankind Pharma 103,325 56.36 12,744 20.90% 2,007 73.37
Zydus Life Science 101,801 19.85 23,511 18.55% 4,615 69.47
Aurobindo Pharma 87,806 25.16 32,346 9.43% 3,484 73.83
Laurus Labs 71,455 79.78 6,813 21.03% 884 80.26

Lactose Company Announcements - News Screener

Screen LACTOSE latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
Date Update Actions
Board Meeting Intimation for The Meeting Scheduled To Be Held On Wednesday 20Th May 2026 -
2026-04-29 Clarification On Significant Price Movement Of The Companys Security -
2026-04-24 Clarification sought from Lactose India Ltd -
2026-04-13 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-03-30 Shareholder Meeting Held On 28Th March 2026 Disclosure Of Voting Results -
2026-03-30 Shareholder Meeting / Postal Ballot-Scrutinizer"s Report -
2026-03-28 Shareholder Meeting / Postal Ballot-Outcome of Court Convened Meeting -
2026-03-27 Closure of Trading Window -
2026-03-27 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-03-27 Corrigendum Notice For Shareholders Meeting - By NCLT Scheduled To Be Convened On Saturday 28Th March 2026 -
2026-02-27 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-02-26 Shareholders Meeting Scheduled To Be Held On Saturday 28Th March 2026- Intimation For Book Closure And Instructions For Remote E-Voting -
2026-02-26 Shareholders Meeting - By NCLT Scheduled To Be Convened On Saturday 28Th March 2026 -
2026-02-16 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-02-13 Results - Financial Results For The Quarter Ended 31St December 2025 -
2026-02-13 Board Meeting Outcome for Outcome Of Board Meeting Held On Friday 13Th February 2026 -
2026-02-09 Board Meeting Intimation for The Meeting Scheduled To Be Held On Friday 13Th February 2026 -
2026-01-30 Intimation For Adoption Of New Line(S) Of Business And Product Development / Product Launch Information -
2026-01-16 Disclosures under Reg. 10(7) of SEBI (SAST) Regulations 2011 -
2026-01-16 Disclosures under Reg. 10(7) of SEBI (SAST) Regulations 2011 -